Naprelan
Product Images NDC 52427-274

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Naprelan (NDC 52427-274). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Almatica Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

375mg (375mg)

The text is a product information sheet for a medication, NDC 52427-272-01, named "PRELAN® S". It contains warnings and dosage information for controlled-release tablets containing 75mg of naproxen sodium. Manufactured by Norwich Pharmaceuticals Inc, each tablet contains 412.5mg of naproxen sodium, equivalent to 375mg of naproxen. The medication is only available on prescription. The text provides instructions for dispensing to patients and a contact number for more information.*

FDA Label Image

500mg (500mg)

This is a prescription drug called NAPRELAN (naproxen sodium). The drug comes in the form of controlled-release tablets, containing 550 mg naproxen. Each tablet has 500 g naproxen equivalent sodium. A medication guide should be given to each patient upon dispensing the medication. For more information, contact Almatica at 1-877-447-7979. It has to be stored at a controlled room temperature of 20° to 25°C (68°F to 77°F) and should be dispensed in a well-closed container. Manufacturing company is Norwich Pharmaceuticals, distributed by Foisn LTD. The full prescribing information is available under NDG 52427.273-75.*

FDA Label Image

750mg (750mg)

Naprelan is a controlled-release tablet medication manufactured by Norwich Pharmaceuticals, Inc. It contains 825mg of naproxen sodium which is equivalent to 750mg naproxen. Each package has 30 tablets and requires a prescription. The medication has BOXED WARNINGS in relation to cardiovascular risks and potential gastrointestinal issues. Naprelan should be dispensed in a well-closed container and accompanied by a medication guide for each patient. Please consult your pharmacist or call Amatica for more information at 1-877-447-7979.*

FDA Label Image

Structure (Structure)

FDA Label Image

Table (Table)

This appears to be a table or figure showing the mean plasma concentration of Naproxen for 24 subjects over a 24 hour period at steady state, with 500 mg of naproxen given every 12 hours and Naprelan® 1000mg given every 24 hours. The values are shown in micrograms per milliliter, with two standard deviations noted. It is not possible to determine the actual values of the concentrations from this text alone.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.